Showing results (211-220 of 316) with videos related to

Sort By:
Pageof 32
European Urology|March 13, 2019
Patient-reported Quality of Life Following Stereotactic Body Radiotherapy and Conventionally Fractionated External Beam Radiotherapy Compared with Active Surveillance Among Men with Localized Prostate CancerDominic H Moon, Ram S Basak, Deborah S Usinger, et al.
Leukemia & Lymphoma|October 6, 2010
Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive diseasePeter H O'Donnell, Andrew S Artz, Samir D Undevia, et al.
Journal of Human Genetics|May 13, 2021
RBL2 bi-allelic truncating variants cause severe motor and cognitive impairment without evidence for abnormalities in DNA methylation or telomeric functionNadra Samra, Shir Toubiana, Hilde Yttervik, et al.
Plos One|December 31, 2021
Correction: A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancerStephanie I Kim, Andy H Szeto, Katherine P Morgan, et al.
The Journal of Urology|January 18, 2012
Impact of distance to a urologist on early diagnosis of prostate cancer among black and white patientsJordan A Holmes, William R Carpenter, Yang Wu, et al.
Plos One|June 21, 2021
A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancerStephanie I Kim, Andy H Szeto, Katherine P Morgan, et al.
Bone Marrow Transplantation|June 18, 2013
A novel clofarabine bridge strategy facilitates allogeneic transplantation in patients with relapsed/refractory leukemia and high-risk myelodysplastic syndromesF Locke, R Agarwal, R Kunnavakkam, et al.
Oncotarget|October 22, 2016
Integrative genomics reveals hypoxia inducible genes that are associated with a poor prognosis in neuroblastoma patientsMark A Applebaum, Aashish R Jha, Clara Kao, et al.
Leukemia & Lymphoma|June 12, 2010
Treatment of therapy-related myeloid neoplasms with high-dose cytarabine/mitoxantrone followed by hematopoietic stem cell transplantLucy A Godley, Uchenna O Njiaju, Margaret Green, et al.
Investigational New Drugs|December 9, 2014
A phase I and pharmacodynamic study of the histone deacetylase inhibitor belinostat plus azacitidine in advanced myeloid neoplasiaOlatoyosi Odenike, Anna Halpern, Lucy A Godley, et al.
Pageof 32